Healthcare's Transformation

Founded in 1988, Reimbursement IQ provides analytical, strategic, and hands-on support services to forward-thinking innovators, entrepreneurs, and executives. With support from our longstanding strategic partners at Central IQ, we ensure client’s category-creating products, services, and solutions generate unparalleled returns on investment (ROIs) and have the best performance, outcomes, and impacts possible.

Our expert team works with stakeholders who are committed to reducing the incidence, prevalence, and cost of diseases and other adverse conditions.

After careful study of our clients’ offerings, we advocate, accelerate, and facilitate access to the healthcare industry’s most safe, effective, and cost-saving products, services, and solutions—especially in direct-to-consumer (DTC) and managed markets.

Our leadership team has served more than two-thirds of the top 25 biopharmaceutical and medical device companies worldwide; scores of forward-looking healthcare providers; and hundreds of pioneering healthcare purchasers.

We offer unique expertise in the data sciences, life sciences, and social sciences—all focused on improving the performance, outcomes, and impacts of policies, programs, projects, people, processes, and products in the healthcare education, and social service sectors.

Contact us to learn more about our industry-transforming work. Call us today at +1 949-336-1691 or schedule a Zoom at https://bit.ly/3MQ2MoG.

Similar Posts

  • Performance, Outcomes, and Impact Analytics

    The Reimbursement IQ subject matter experts—in collaboration with our longstanding strategic partners at Central IQ—are offering briefings on “Performance, Outcomes, and Impact Analytics” to innovators, entrepreneurs, and executives within Life Science companies. These Zoom-based or remote briefings can help transform Medical Affairs, HEOR/Value, Market Access, and Commercialization (Marketing and Sales) functions by revealing the extreme…

  • A Payment Manifesto

    Reimbursement IQ team members—and our longstanding partners at Central IQ—deliver source-of-payment strategies and support services that reduce the incidence, prevalence, and cost of diseases and other health challenges. We facilitate patient access to the industry’s most safe, effective, and cost-saving healthcare products and services in direct-to-consumer (DTC) and managed markets (the latter subject to third-party…

  • The New Gold Standard

    Impact analytics are raising the bar in value-based contracting (VBC) and outcomes-based compensation (OBC). With guidance from business coalitions on health, human capital consulting firms, and data science organizations; pioneering employers and other healthcare purchasers are sharing a broad range of pharmacy benefit and medical insurance claims data. They’re studying correlated and causal relationships among payers,…

  • Market Access

    In the U.S. healthcare market, market access refers to the degree to which health-related products, services, and solutions can be identified, researched, purchased, used, and evaluated by individuals, organizations, and communities.  Complete market access is evidenced by the unrestricted flow of information, money, manpower (e.g., clinicians), materials (e.g., products), and methods (e.g., services) under “free market” conditions…